Concert Pharmaceuticals to Present at Upcoming Investor Conferences
29 Agosto 2019 - 6:00AM
Business Wire
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced
that it will participate at the following upcoming investor
conferences:
- The H.C. Wainwright 21st Annual Healthcare Conference on
September 9, 2019 at 8:45 a.m. ET in New York, NY;
- The 3rd Annual Janney Healthcare Conference on September 10,
2019 at 9:05 a.m. ET in New York, NY; and
- The Cantor Global Healthcare Conference on October 3, 2019 at
5:20 p.m. ET in New York, NY.
Live webcasts of the presentations may be accessed in the
Investors section of the Company’s website at
www.concertpharma.com. Please log on to the Concert website
approximately 15 minutes prior to the scheduled webcast to ensure
adequate time for any software downloads that may be required. A
replay of the conference webcasts will be available on Concert’s
website for two weeks following the presentations.
About Concert Concert Pharmaceuticals is a clinical stage
biopharmaceutical company focused on applying its DCE Platform®
(deuterated chemical entity platform) to create novel medicines
designed to treat serious diseases and address unmet patient needs.
The Company’s approach starts with previously studied compounds,
including approved drugs, in which deuterium substitution has the
potential to enhance clinical safety, tolerability or efficacy.
Concert’s pipeline of innovative medicines targets autoimmune
diseases and central nervous systems (CNS) disorders. For more
information please visit www.concertpharma.com or follow us on
Twitter at @ConcertPharma or on LinkedIn.
Concert Pharmaceuticals Inc., the CoNCERT
Pharmaceuticals Inc. logo and DCE Platform are registered
trademarks of Concert Pharmaceuticals, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190829005072/en/
Justine Koenigsberg (781) 674-5284 ir@concertpharma.com
Concert Pharmaceuticals (NASDAQ:CNCE)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Concert Pharmaceuticals (NASDAQ:CNCE)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
Real-Time news about Concert Pharmaceuticals Inc (NASDAQ): 0 recent articles
Más de Concert Pharmaceuticals, Inc. Artículos de Noticias